CANF · Can-Fite BioPharma Ltd. · Documents
Market Cap
$5.73M
Shares
3.03M
Volume · Oct 21
10.82K
Avg daily vol (3M)
358.64K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2025-07-28 | — | |
| 6-K | — | 2025-06-30 | — | |
| 6-K | — | 2025-06-23 | — | |
| 6-K | — | 2025-06-16 | — | |
| 6-K | — | 2025-05-16 | — | |
| 6-K | — | 2025-05-05 | — | |
| 6-K | — | 2025-04-17 | — | |
| 6-K | — | 2025-04-15 | — | |
| 6-K | — | 2025-04-14 | — | |
| 6-K | — | 2025-04-14 | — | |
| 6-K | — | 2025-04-14 | — | |
| 20-F | — | 2025-04-14 | 2024-12-31 | |
| 6-K | — | 2025-03-24 | — | |
| 6-K | — | 2025-03-20 | — | |
| 6-K | — | 2025-03-19 | — | |
| 6-K | — | 2025-03-18 | — | |
| 6-K | — | 2025-03-03 | — | |
| 6-K | — | 2025-02-18 | — | |
| 6-K | — | 2025-02-05 | — | |
| 6-K | — | 2025-01-27 | — | |
| 6-K | — | 2024-12-30 | — | |
| 6-K | — | 2024-12-04 | — | |
| 6-K | — | 2024-11-12 | 2024-11-11 | |
| 6-K | — | 2024-11-04 | — | |
| 6-K | — | 2024-10-18 | — | |
| 6-K | — | 2024-10-09 | — | |
| 6-K | — | 2024-09-24 | — | |
| 6-K | — | 2024-09-16 | — | |
| 6-K | — | 2024-08-30 | — | |
| 6-K | — | 2024-08-29 | 2024-06-30 | |
| 6-K | — | 2024-08-12 | — | |
| 6-K | — | 2024-08-09 | — | |
| 6-K | — | 2024-07-29 | — | |
| 6-K | — | 2024-07-11 | — | |
| 6-K | — | 2024-07-03 | — | |
| 6-K | — | 2024-07-01 | — | |
| 6-K | — | 2024-06-28 | — | |
| 6-K | — | 2024-06-26 | — | |
| 6-K | — | 2024-06-24 | — | |
| 6-K | — | 2024-06-10 | — | |
| 6-K/A | — | 2024-06-07 | — | |
| 6-K | — | 2024-06-05 | — | |
| 6-K | — | 2024-05-29 | — | |
| 6-K | — | 2024-05-22 | — | |
| 6-K | — | 2024-05-13 | — | |
| 6-K | — | 2024-05-09 | — | |
| 6-K | — | 2024-05-06 | — | |
| 6-K | — | 2024-04-25 | — | |
| 6-K | — | 2024-04-15 | — | |
| 6-K | — | 2024-04-03 | — |
Showing 51–100 of 279 filings